Skip to main content
Log in

Etomidat zur „rapid sequence induction“ bei schwerem Trauma

Etomidate for rapid sequence induction in patients with major trauma

  • Konzepte - Stellungnahmen - Leitlinien
  • Published:
Notfall + Rettungsmedizin Aims and scope Submit manuscript

Zusammenfassung

Das Anästhetikum Etomidat ist zur Einleitung einer Notfallnarkose umstritten. Obwohl es wegen seiner Kreislaufneutralität geschätzt wird, begünstigt es die Entstehung einer Nebenniereninsuffizienz. Der Gebrauch wird daher in der S3-Leitlinie Polytrauma/Schwerverletzten-Behandlung der Deutschen Gesellschaft für Unfallchirurgie nicht empfohlen. Die Leitlinien der Eastern Association for the Surgery of Trauma und des Advanced Trauma Life Support® schließen den Gebrauch hingegen nicht aus. Beide Leitlinien basieren auf vergleichbarer Evidenz, die in der hier vorgenommenen Rückschau dargestellt wird. Ein klarer Nachweis von schädlichen Effekten konnte demnach bisher nicht erbracht werden. Es besteht jedoch Konsens darüber, dass aussagekräftige Studien für eine abschließende Beurteilung bisher fehlen.

Wir führten daher in Pubmed® eine strukturierte Literatursuche nach neuen Studien durch, die bei Fertigstellung der o. g. Leitlinien noch nicht verfügbar waren und identifizierten 14 Studien (4 systematische Reviews/Metaanalysen, 1 systematisches Review, 3 randomisierte kontrollierte Studien, 3 Kohortenstudien und 3 Post-hoc-Analysen), die in diesem Artikel zusammengefasst dargestellt werden. Jedoch kann auch keine dieser aktuellen Studien Nutzen und Risiken einer einmaligen Bolusgabe von Etomidat zur Einleitung einer Notfallnarkose bei Traumapatienten mit ausreichend guter Aussagekraft im Hinblick auf Überleben, Komplikationen und Behandlungsverlauf aufklären. Zusammenfassend bleibt trotz neuer Evidenz weiterhin unklar, welche der beiden widersprüchlichen Empfehlungen für die tägliche Praxis beachtet werden sollte. Etomidat sollte bei Verfügbarkeit alternativer Medikamente, deren Anwendung sicher beherrscht wird, nur im Rahmen von kontrollierten Studien eingesetzt werden. Auf eine etomidatinduzierte Nebenniereninsuffizienz ist dann zu achten.

Abstract

The use of etomidate for inducing emergency anesthesia is controversial. Although it is known for its circulatory neutrality, it promotes the occurrence of adrenal insufficiency. Thus its use is not recommended in the S3 Guideline on Treatment of Patients with Severe and Multiple Injuries by the German Trauma Society. The guidelines of the Eastern Association for the Surgery of Trauma and the Advanced Trauma Life Support® manual do not rule out its use. Both guidelines are based on comparative evidence shown in this review: Clear evidence for harmful effects could not be supplied. There is consensus on the lack of significant studies hitherto for a concluding judgment. We carried out a structured literature search in Pubmed® for current studies that had not been published at the time the guideline was completed and identified 14 studies (four systematic reviews/meta-analyses, one non-systematic review, three randomized controlled trials, three cohort studies, and three post hoc analyses), which are summarized in the following. None of the current studies is able to clarify the benefits and risks of a one-time bolus dose of etomidate for inducing emergency anesthesia in trauma patients with regards to survival, complications, and course of treatment. In conclusion, despite new evidence, it is still unclear which of the original controversial recommendations should be adhered to in day-to-day practice. As long as there is an alternative medication that the provider knows how to handle carefully, the use of etomidate should be restricted to controlled clinical trials. In this case, an etomidate-induced adrenal insufficiency should be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Deutsche Gesellschaft Für Unfallchirurgie (2011) S3-Leitlinie Polytrauma/Schwerverletzten-Behandlung. http://www.awmf.org/leitlinien/detail/ll/012-019.html

  2. American College of Surgeons Committee on Trauma (Hrsg) (2012) Airway and ventilatory management. American College of Surgeons, Chicago

  3. Forman SA (2011) Clinical and molecular pharmacology of etomidate. Anesthesiology 114:695–707

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  4. Mayglothling J, Duane TM, Gibbs M et al (2012) Emergency tracheal intubation immediately following traumatic injury: an Eastern Association for the Surgery of Trauma practice management guideline. J Trauma Acute Care Surg 73:S333–S340

    Article  PubMed  Google Scholar 

  5. Lauzier F, Turgeon AF (2012) Etomidate: buy now, pay later?*. Crit Care Med 40:3086–3087

    Article  PubMed  Google Scholar 

  6. Cotton BA, Guillamondegui OD, Fleming SB et al (2008) Increased risk of adrenal insufficiency following etomidate exposure in critically injured patients. Arch Surg 143:62–67 (discussion 67)

    Article  PubMed  Google Scholar 

  7. Hildreth AN, Mejia VA, Maxwell RA et al (2008) Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. J Trauma 65:573–579

    Article  PubMed  CAS  Google Scholar 

  8. Jabre P, Combes X, Lapostolle F et al (2009) Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet 374:293–300

    Article  PubMed  CAS  Google Scholar 

  9. Warner KJ, Cuschieri J, Jurkovich GJ et al (2009) Single-dose etomidate for rapid sequence intubation may impact outcome after severe injury. J Trauma 67:45–50

    Article  PubMed  CAS  Google Scholar 

  10. Howick J, Phillips B, Ball C et al (2009) Oxford Centre for Evidence-based Medicine – levels of evidence (Update 2009). Centre for Evidence Based Medicine, Oxford

  11. Nieman LK (2013) Diagnosis of adrenal insufficiency in adults. In: Martin KA (Hrsg) UpToDate. Wolters Kluwer Health, Waltham, S 1

  12. Nieman LK (2013) Evaluation of the response to ACTH in adrenal insufficiency. In: Martin KA (Hrsg) UpToDate. Wolters Kluwer Health, Waltham, S 1

  13. Marik PE, Pastores SM, Annane D et al (2008) Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 36:1937–1949

    Article  PubMed  CAS  Google Scholar 

  14. Annane D, Maxime V, Ibrahim F et al (2006) Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 174:1319–1326

    Article  PubMed  Google Scholar 

  15. Nieman LK (2014) Measurement of cortisol in serum and saliva. In: Martin KA (Hrsg) UpToDate. Wolters Kluwer Health, Waltham, S 1

  16. Gattas DJ, Dan A, Myburgh J et al (2012) Fluid resuscitation with 6% hydroxyethyl starch (130/0.4) in acutely ill patients: an updated systematic review and meta-analysis. Anesth Analg 114:159–169

    Article  PubMed  Google Scholar 

  17. Ray DC, Mckeown DW (2012) Etomidate for critically ill patients. Pro: yes we can use it. Eur J Anaesthesiol 29:506–510

    Article  PubMed  CAS  Google Scholar 

  18. De La Grandville B, Arroyo D, Walder B (2012) Etomidate for critically ill patients. Con: do you really want to weaken the frail? Eur J Anaesthesiol 29:511–514

    Article  Google Scholar 

  19. Albert SG, Ariyan S, Rather A (2011) The effect of etomidate on adrenal function in critical illness: a systematic review. Intensive Care Med 37:901–910

    Article  PubMed  CAS  Google Scholar 

  20. Archambault P, Dionne CE, Lortie G et al (2012) Adrenal inhibition following a single dose of etomidate in intubated traumatic brain injury victims. CJEM 14:270–282

    PubMed  Google Scholar 

  21. Asehnoune K, Mahe PJ, Seguin P et al (2012) Etomidate increases susceptibility to pneumonia in trauma patients. Intensive Care Med 38:1673–1682

    Article  PubMed  CAS  Google Scholar 

  22. Chan CM, Mitchell AL, Shorr AF (2012) Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta-analysis*. Crit Care Med 40:2945–2953

    Article  PubMed  CAS  Google Scholar 

  23. Cherfan AJ, Tamim HM, Aljumah A et al (2011) Etomidate and mortality in cirrhotic patients with septic shock. BMC Clin Pharmacol 11:22

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  24. Cuthbertson BH, Sprung CL, Annane D et al (2009) The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med 35:1868–1876

    Article  PubMed  CAS  Google Scholar 

  25. Dmello D, Taylor S, O’brien J et al (2010) Outcomes of etomidate in severe sepsis and septic shock. Chest 138:1327–1332

    Article  PubMed  Google Scholar 

  26. Edwin SB, Walker PL (2010) Controversies surrounding the use of etomidate for rapid sequence intubation in patients with suspected sepsis. Ann Pharmacother 44:1307–1313

    Article  PubMed  CAS  Google Scholar 

  27. Hohl CM, Kelly-Smith CH, Yeung TC et al (2010) The effect of a bolus dose of etomidate on cortisol levels, mortality, and health services utilization: a systematic review. Ann Emerg Med 56:105–113 e105

    Article  PubMed  Google Scholar 

  28. Komatsu R, You J, Mascha EJ et al (2013) Anesthetic induction with etomidate, rather than propofol, is associated with increased 30-day mortality and cardiovascular morbidity after noncardiac surgery. Anesth Analg 117:1329–1337

    Article  PubMed  CAS  Google Scholar 

  29. Morel J, Salard M, Castelain C et al (2011) Haemodynamic consequences of etomidate administration in elective cardiac surgery: a randomized double-blinded study. Br J Anaesth 107:503–509

    Article  PubMed  CAS  Google Scholar 

  30. Payen JF, Dupuis C, Trouve-Buisson T et al (2012) Corticosteroid after etomidate in critically ill patients: a randomized controlled trial. Crit Care Med 40:29–35

    Article  PubMed  CAS  Google Scholar 

  31. Roberts DJ, Hall RI, Kramer AH et al (2011) Sedation for critically ill adults with severe traumatic brain injury: a systematic review of randomized controlled trials. Crit Care Med 39:2743–2751

    Article  PubMed  CAS  Google Scholar 

  32. Tekwani KL, Watts HF, Sweis RT et al (2010) A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study. Ann Emerg Med 56:481–489

    Article  PubMed  Google Scholar 

  33. Diaz-Guzman E, Mireles-Cabodevila E, Heresi GA et al (2010) A comparison of methohexital versus etomidate for endotracheal intubation of critically ill patients. Am J Crit Care 19:48–54

    Article  PubMed  Google Scholar 

  34. Moller Petrun A, Kamenik M (2013) Bispectral index-guided induction of general anaesthesia in patients undergoing major abdominal surgery using propofol or etomidate: a double-blind, randomized, clinical trial. Br J Anaesth 110:388–396

    Article  Google Scholar 

  35. Price B, Arthur AO, Brunko M et al (2013) Hemodynamic consequences of ketamine vs etomidate for endotracheal intubation in the air medical setting. Am J Emerg Med 31:1124–1132

    Article  PubMed  Google Scholar 

  36. Singh R, Choudhury M, Kapoor PM et al (2010) A randomized trial of anesthetic induction agents in patients with coronary artery disease and left ventricular dysfunction. Ann Cardiac Anaesth 13:217–223

    Article  Google Scholar 

  37. Wu J, Yao S, Wu Z et al (2013) A comparison of anesthetic regimens using etomidate and propofol in patients undergoing first-trimester abortions: double-blind, randomized clinical trial of safety and efficacy. Contraception 87:55–62

    Article  PubMed  CAS  Google Scholar 

  38. Banh KV, James S, Hendey GW et al (2012) Single-dose etomidate for intubation in the trauma patient. J Emerg Med 43:e277–e282

    Article  PubMed  Google Scholar 

  39. Iribarren JL, Jimenez JJ, Hernandez D et al (2010) Relative adrenal insufficiency and hemodynamic status in cardiopulmonary bypass surgery patients. A prospective cohort study. J Cardiothorac Surg 5:26

    Article  PubMed  PubMed Central  Google Scholar 

  40. Jung B, Clavieras N, Nougaret S et al (2012) Effects of etomidate on complications related to intubation and on mortality in septic shock patients treated with hydrocortisone: a propensity score analysis. Crit Care (London, England) 16:R224

  41. Mcphee LC, Badawi O, Fraser GL et al (2013) Single-dose etomidate is not associated with increased mortality in ICU patients with sepsis: analysis of a large electronic ICU database. Crit Care Med 41:774–783

    Article  PubMed  CAS  Google Scholar 

  42. Roquilly A, Mahe PJ, Seguin P et al (2011) Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study. JAMA 305:1201–1209

    Article  PubMed  CAS  Google Scholar 

  43. Van Den Heuvel I, Wurmb TE, Bottiger BW et al (2013) Pros and cons of etomidate – more discussion than evidence? Curr Opin Anaesthesiol 26:404–408

    Article  Google Scholar 

Download references

Danksagung

Die Autoren danken Frau Carolin Braun für die Assistenz bei der Erstellung des Manuskripts.

Einhaltung ethischer Richtlinien

Interessenkonflikt. H. Trentzsch, M. Münzberg, J. Luxen, B. Urban und S. Prückner geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag enthält keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Trentzsch.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Trentzsch, H., Münzberg, M., Luxen, J. et al. Etomidat zur „rapid sequence induction“ bei schwerem Trauma. Notfall Rettungsmed 17, 521–535 (2014). https://doi.org/10.1007/s10049-014-1899-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10049-014-1899-7

Schlüsselwörter

Keywords

Navigation